Research article summary (published 29 Apr 2009):

Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Cohen, Dan (D); Correll, Christoph U (CU);

Affiliation: Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. d.cohen(-atsign-)ggz-nhn.nl

Journal and publication information

Publication Type: Journal Article

Journal: The Journal of clinical psychiatry (J Clin Psychiatry), published in United States. (Language: eng)

Reference: 2009-May; vol 70 (issue 5) : pp 765-6

Dates: Created 2009/06/25; Completed 2009/07/22;

PMID: 19552870, status: MEDLINE (last retrieved date: 8/20/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Antipsychotic Agents - adverse effects Benzodiazepines - adverse effects Clozapine - adverse effects Diabetes Mellitus - chemically induced; diagnosis; epidemiology Diabetic Ketoacidosis - chemically induced; diagnosis; epidemiology Dibenzothiazepines - adverse effects Humans

Humans Mass Screening Piperazines - adverse effects Predictive Value of Tests Prospective Studies Quinolones - adverse effects Severity of Illness Index

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Antipsychotic Agents (0) ; Dibenzothiazepines (0) ; Piperazines (0) ; Quinolones (0) ; quetiapine (0) ; Benzodiazepines (12794-10-4) ; aripiprazole (129722-12-9) ; olanzapine (132539-06-1) ; Clozapine (5786-21-0)

Related articles

These are the most related articles currently in our database:

• New-onset diabetes and ketoacidosis with atypical antipsychotics. 30 Dec 2002
• Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. 30 Aug 2004
• A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine. 30 May 2004
• FDA warns antipsychotic drugs may be risky for elderly. 23 May 2005
• Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. 29 Sep 2005
• A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania. 30 Dec 2005
• Metabolic effects of the atypical antipsychotics. 30 Jul 2007
• Diabetes mellitus during olanzapine and quetiapine treatment in Japan. 30 Jan 2005
• Atypical antipsychotics and diabetes mellitus: an association. 29 Apr 2004
• Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. 29 Jun 2008

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.